Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Clinical Research Article
  • Published:

Serum uric acid/creatinine ratio and metabolic-associated fatty liver disease risks in children

Abstract

Objectives

To investigate the correlation between serum uric acid/creatinine ratio (SUA/Cr) and Metabolic-associated fatty liver disease (MAFLD) in children.

Methods

1387 participants aged 4–15 who underwent health examinations from 1/2020–12/2023 were included. Clinical indicators were compared and analyzed.

Results

Overweight/obese group had elevated levels compared to non-overweight/obese group in male proportion, uric acid (UA), serum uric acid/creatinine ratio (SUA/Cr), systolic blood pressure (SBP), diastolic blood pressure (DBP), alanine aminotransferase (ALT), gamma-glutamyltransferase(GGT), total protein(TP), albumin(ALB), globulin(GLO), and serum creatinine(SCr) (p < 0.001, Kruskal–Wallis test). As SUA/Cr increased, UA, ALT, ALP, TP, GGT levels and the prevalence rates of overweight/obesity rose, while SCr levels fell (p < 0.05, Jonckheere-Terpstra test), and positively related to body mass index (BMI) (p < 0.05). The OR for overweight/obesity increased in higher SUA/Cr quartile groups, as Q3 (OR = 2.399, 95% confidence interval CI = 1.554–3.703) and Q4 (OR = 5.044, 95% CI = 3.281–7.754). The SUA/Cr exhibited an AUC of 0.828 (95% CI = 0.764–0.892, p < 0.001) in predicting overweight/obesity and elevated ALT levels, with a specificity of 0.764 and sensitivity of 0. 805.

Conclusions

Children with overweight/obesity have higher liver enzymes, and elevated SUA/Cr levels may predict an increased incidence of overweight/obesity and hepatic injury.

Impact

  • This study found a close association between serum uric acid/creatinine ratio (SUA/Cr) and risk factors for Metabolic-associated fatty liver disease (MAFLD) in children.

  • SUA/Cr may be an indicator of risk factors for MAFLD in children.

  • Elevated SUA/Cr levels may predict an increased incidence of overweight/obesity and hepatic injury.

  • Providing an easily accessible non-invasive biomarker for predicting and preventing MAFLD in children.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: ROC analysis of SUA/Cr for predicting overweight/obesity and abnormal ALT.

Similar content being viewed by others

Data availability

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. Gofton, C., Upendran, Y., Zheng, M. H. & George, J. MAFLD: how is it different from NAFLD?. Clin. Mol. Hepatol. 29, S17–S31 (2023).

    Article  PubMed  Google Scholar 

  2. Rinella, M. E. et al. AASLD Practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology 77, 1797–1835 (2023).

    Article  PubMed  Google Scholar 

  3. Lim, G. E. H. et al. An observational data meta-analysis on the differences in prevalence and risk factors between MAFLD vs NAFLD. Clin. Gastroenterol. Hepatol. 21, 619–629 (2023).

    Article  PubMed  Google Scholar 

  4. Chen, Y. L. et al. Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study. BMC Gastroenterol. 21, 212 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Le Garf, S., Nègre, V., Anty, R. & Gual, P. Metabolic fatty liver disease in children: a growing public health problem. Biomedicines 9, 1915 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  6. Dikaiou, P. et al. Obesity, overweight and risk for cardiovascular disease and mortality in young women. Eur. J. Prev. Cardiol. 28, 1351–1359 (2021).

    Article  PubMed  Google Scholar 

  7. Collaboration, N. C. D. R. F. Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet 403, 1027–1050 (2024).

    Article  Google Scholar 

  8. Lister, N. B. et al. Child and adolescent obesity. Nat. Rev. Dis. Prim. 9, 24 (2023).

    Article  PubMed  Google Scholar 

  9. Carrasquilla, G. D., Ängquist, L., Sørensen, T. I. A., Kilpeläinen, T. O. & Loos, R. J. F. Child-to-adult body size change and risk of type 2 diabetes and cardiovascular disease. Diabetologia 67, 864–873 (2024).

    Article  PubMed  Google Scholar 

  10. Di Cesare, M. et al. The epidemiological burden of obesity in childhood: a worldwide epidemic requiring urgent action. BMC Med. 17, 212 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  11. Okunogbe, A. et al. Economic impacts of overweight and obesity: current and future estimates for 161 countries. BMJ Glob. Health 7, e009773 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  12. Pan, X. F., Wang, L. & Pan, A. Epidemiology and determinants of obesity in China. Lancet Diabetes Endocrinol. 9, 373–392 (2021).

    Article  PubMed  Google Scholar 

  13. Eslam, M. et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J. Hepatol. 73, 202–209 (2020).

    Article  PubMed  Google Scholar 

  14. Spiga, R. et al. Uric Acid Is Associated with inflammatory biomarkers and induces inflammation via activating the NF-κB signaling pathway in HepG2 cells. Arterioscler Thromb. Vasc. Biol. 37, 1241–1249 (2017).

    Article  CAS  PubMed  Google Scholar 

  15. Russo, E. et al. Fructose and uric acid: major mediators of cardiovascular disease risk starting at pediatric age. Int. J. Mol. Sci. 21, 4473 (2020).

    Article  Google Scholar 

  16. Zeng, J. et al. Association between serum uric acid and obesity in Chinese adults: a 9-year longitudinal data analysis. BMJ Open 11, e041919 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  17. Wang, A. et al. Metabolic Factors Mediate the Association between serum uric acid to serum creatinine ratio and cardiovascular disease. J. Am. Heart Assoc. 10, e023054 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Zeng, J. et al. Prevalence and incidence of MAFLD and associated anthropometric parameters among prepubertal children of the Shanghai Birth Cohort. Hepatol. Int. 17, 1416–1428 (2023).

    Article  PubMed  Google Scholar 

  19. Bergmann, K. et al. Diagnostic performance of biomarker-based scores as predictors of metabolic dysfunction-associated fatty liver disease risk in healthy children. Nutrients 15, 3667 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Deng, F. et al. Association between body mass index and serum uric acid: mediation analysis involving liver enzymes indicators. BMC Public Health 24, 3007 (2024).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. She, D. et al. Serum uric acid to creatinine ratio and risk of metabolic syndrome in patients with overweight/obesity. Diabetes Metab. Syndr. Obes. 16, 3007–3017 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. van Dam, M., Pottel, H., Delanaye, P. & Vreugdenhil, A. C. E. The evaluation of kidney function estimation during lifestyle intervention in children with overweight and obesity. Pediatr. Nephrol. 39, 3271–3278 (2024).

    Article  PubMed  PubMed Central  Google Scholar 

  23. Miake, J. et al. Impact of hyper- and hypo-uricemia on kidney function. Biomedicines 11, 1258 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Su, M. et al. Metformin alleviates hyperuricaemia-induced serum FFA elevation and insulin resistance by inhibiting adipocyte hypertrophy and reversing suppressed white adipose tissue beiging. Clin. Sci. 134, 1537–1553 (2020).

    Article  CAS  Google Scholar 

  25. Jiao, L. et al. The impact of chrysanthemi indici flos-enriched flavonoid part on the model of hyperuricemia based on inhibiting synthesis and promoting excretion of uric acid. J. Ethnopharmacol. 333, 118488 (2024).

    Article  CAS  PubMed  Google Scholar 

  26. Kawamoto, R., Kikuchi, A., Ninomiya, D., Tokumoto, Y. & Kumagi, T. Serum uric acid to creatinine ratio is a useful predictor of all-cause mortality among hypertensive patients. Clin. Hypertens. 29, 10 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  27. Gill, D. et al. Urate, blood pressure, and cardiovascular disease: evidence from Mendelian randomization and meta-analysis of clinical trials. Hypertension 77, 383–392 (2021).

    Article  CAS  PubMed  Google Scholar 

  28. Sookoian, S. & Pirola, C. J. The serum uric acid/creatinine ratio is associated with nonalcoholic fatty liver disease in the general population. J. Physiol. Biochem. 79, 891–899 (2023).

    Article  CAS  PubMed  Google Scholar 

  29. Chen, L., Zhu, Z., Ye, S. & Zheng, M. The serum uric acid to serum creatinine ratio is an independent risk factor for diabetic kidney disease. Diabetes Metab. Syndr. Obes. 15, 3693–3703 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank Miaosang Xu and Chunsheng Wu for proving software support and development.

Author information

Authors and Affiliations

Authors

Contributions

Bi Chen collected data, drafted the initial manuscript, and critically reviewed and revised the manuscript for important intellectual content. Xiaoning Qu conceptualized the study, collected data, carried out the initial analyses, and critically reviewed and revised the manuscript for important intellectual content. Ting Li carried out the initial statistical analyses and critically reviewed and revised the manuscript. Minghua Jiang conceptualized and designed the study, reviewed, and revised the manuscript for important intellectual content. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.

Corresponding author

Correspondence to Minghua Jiang.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, B., Qu, X., Li, T. et al. Serum uric acid/creatinine ratio and metabolic-associated fatty liver disease risks in children. Pediatr Res (2025). https://doi.org/10.1038/s41390-025-04219-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41390-025-04219-2

Search

Quick links